Cagrilintide Dosage Chart & Schedule Guide.
Cagrilintide is a long-acting amylin analog that reduces appetite and slows gastric emptying. It follows a gradual 5-step titration over 16 weeks to reach the 2.4 mg maintenance dose and minimize gastrointestinal side effects.
Half-Life
~7–8 days
Injection
Subcutaneous
Frequency
Once weekly
Storage
2 – 8 °C
Titration Schedule
Standard dose escalation from 0.25 mg to the 2.4 mg maintenance dose over 16 weeks. Each step lasts 4 weeks.
Vials vary in concentration. Use the calculator below to find your exact draw volume.
0.25 mg
per injection · Weeks 1 – 4
Frequency
1× / week
Monthly Total
1.0 mg
Purpose
GI adaptation
0.25 mg/wk
0.5 mg
per injection · Weeks 5 – 8
Frequency
1× / week
Monthly Total
2.0 mg
Purpose
Dose escalation
0.5 mg/wk
1.0 mg
per injection · Weeks 9 – 12
Frequency
1× / week
Monthly Total
4.0 mg
Purpose
Therapeutic range
1.0 mg/wk
1.7 mg
per injection · Weeks 13 – 16
Frequency
1× / week
Monthly Total
6.8 mg
Purpose
Continued escalation
1.7 mg/wk
2.4 mg
per injection · Week 17 onward
Frequency
1× / week
Monthly Total
9.6 mg
Purpose
Maintenance dose
2.4 mg/wk
Pick Your Injection Day
Cagrilintide is injected once per week on the same day. Choose whichever day fits your routine best and stick to it.
| Day | Mon | Tue | Wed | Thu | Fri | Sat | Sun |
|---|---|---|---|---|---|---|---|
| Option A | |||||||
| Option B | |||||||
| Option C |
Cagrilintide Reconstitution Calculator
Enter your vial size, how much bacteriostatic water you added, and your target dose — we will tell you exactly how much to draw.
Standard insulin syringe
Concentration
1.00 mg/mL
Draw volume
0.250 mL
= 0.25 mg ÷ 1.00 mg/mL
Units to draw (1 mL syringe)
25 units
1 mL Syringe
25 IUTips & Notes
Timing & Consistency
Inject on the same day each week at any time of day, with or without food. If you miss a dose and fewer than 5 days have passed, inject as soon as possible. If 5 or more days have passed, skip it and resume the following week.
Injection Sites
Inject subcutaneously into the abdomen, front of thigh, or upper arm. Rotate sites each week to prevent lipodystrophy. If co-administering with semaglutide (CagriSema), use different injection sites for each peptide.
Managing Side Effects
Nausea, vomiting, and reduced appetite are most common during dose escalation. If GI side effects are poorly tolerated, stay at the current dose for an additional 4 weeks before increasing. Do not skip titration steps.
Storage
Store unreconstituted vials at 2 – 8 °C in the refrigerator. After reconstitution, keep refrigerated and use within 28 days. Never freeze cagrilintide — freezing degrades the peptide.
Disclaimer: This content is for informational purposes only. Cagrilintide is an investigational compound and not approved for individual use. Always consult a qualified healthcare professional before starting or adjusting any treatment. PeptideDeck is not responsible for individual use.